Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP
Authors:
- Bjørn A NexøBNBjørn A Nexø
- Ulla VogelUVUlla Vogel
- Anja OlsenAOAnja Olsen
- Mette NyegaardMNMette Nyegaard
- Zuzanna BukowyZBZuzanna Bukowy
- Eszter RockenbauerEREszter Rockenbauer
- Xiuqing ZhangXZXiuqing Zhang
- Cemile KocaCKCemile Koca
- Mette MainsMMMette Mains
- Bettina HansenBHBettina Hansen
- Anne HedemandAHAnne Hedemand
- Anette KjeldgaardAKAnette Kjeldgaard
Open Access
- 27 June 2008
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 9 (1) , 56
Abstract
Previous results have suggested an association of the region of 19q13.3 with several forms of cancer. In the present study, we investigated 27 public markers within a previously identified 69 kb stretch of chromosome 19q for association with breast cancer by using linkage disequilibrium mapping. The study groups included 434 postmenopausal breast cancer cases and an identical number of individually matched controls. Studying one marker at a time, we found a region spanning the gene RAI (alias PPP1R13L or iASPP) and the 5' portion of XPD to be associated with this cancer. The region corresponds to a haplotype block, in which there seems to be very limited recombination in the Danish population. Studying combinations of markers, we found that two to four neighboring markers gave the most consistent and strongest result. The haplotypes with strongest association with cancers were located in the gene RAI and just 3' to the gene. Coinciding peaks were seen in the region of RAI in groups of women of different age. In a follow-up to these results we sequenced 10 cases and 10 controls in a 44 kb region spanning the peaks of association. This revealed 106 polymorphisms, many of which were not in the public databases. We tested an additional 44 of these for association with disease and found a new tandem repeat marker, called RAI-3'd1, located downstream of the transcribed region of RAI, which was more strongly associated with breast cancer than any other marker we have tested (RR = 2.44 (1.41–4.23, p = 0.0008, all cases; RR = 6.29 (1.49–26.6), p = 0.01, cases up to 55 years of age). We expect the marker RAI-3'd1 to be (part of) the cause for the association of the chromosome 19q13.3 region's association with cancer.Keywords
This publication has 29 references indexed in Scilit:
- A haplotype of polymorphisms in ASE-1, RAI and ERCC1and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a danish prospective case-cohort studyBMC Cancer, 2008
- Expression of the RAI gene is conducive to apoptosis: Studies of induction and interferenceExperimental Cell Research, 2007
- Bladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle–Control GenesThe American Journal of Human Genetics, 2006
- ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of DanesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2006
- Polymorphisms in RAI and in genes of nucleotide and base excision repair are not associated with risk of testicular cancerCancer Letters, 2005
- Two regions in chromosome 19q13.2-3 are associated with risk of lung cancerMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- iASPP oncoprotein is a key inhibitor of p53 conserved from worm to humanNature Genetics, 2003
- Proper controls for SNP studies?Carcinogenesis, 2002
- A New Statistical Method for Haplotype Reconstruction from Population DataThe American Journal of Human Genetics, 2001
- Identification of a Novel Inhibitor of Nuclear Factor-κB, RelA-associated InhibitorJournal of Biological Chemistry, 1999